L-Asparaginase from the BCG strain of Mycobacterium bovis. I. Purification and in vitro immunosuppressive properties.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000918:Antibody Specificity; D001215:Asparaginase / Q000302:isolation & purification* / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002850:Chromatography, Gel; D003864:Depression, Chemical; D004586:Electrophoresis; D004591:Electrophoresis, Polyacrylamide Gel; D004926:Escherichia coli / Q000201:enzymology; D006168:Guinea Pigs; D007106:Immune Sera; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007166:Immunosuppressive Agents / Q000302:isolation & purification*; D009163:Mycobacterium bovis / Q000201:enzymology*; D011817:Rabbits / Q000276:immunology; D012882:Skin Tests; D013060:Speech / Q000378:metabolism; D013154:Spleen / Q000276:immunology; D013936:Thymidine / Q000378:metabolism
D007106:Immune Sera; D007166:Immunosuppressive Agents; D001215:Asparaginase; D013936:Thymidine